ES555200A0 - Procedimiento para la produccion de derivados del morfinano - Google Patents
Procedimiento para la produccion de derivados del morfinanoInfo
- Publication number
- ES555200A0 ES555200A0 ES555200A ES555200A ES555200A0 ES 555200 A0 ES555200 A0 ES 555200A0 ES 555200 A ES555200 A ES 555200A ES 555200 A ES555200 A ES 555200A ES 555200 A0 ES555200 A0 ES 555200A0
- Authority
- ES
- Spain
- Prior art keywords
- procedure
- production
- morphinan derivatives
- morphinan
- derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- INAXVFBXDYWQFN-XHSDSOJGSA-N morphinan Chemical class C1C2=CC=CC=C2[C@]23CCCC[C@H]3[C@@H]1NCC2 INAXVFBXDYWQFN-XHSDSOJGSA-N 0.000 title 1
- 229940051807 opiod analgesics morphinan derivative Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/22—Bridged ring systems
- C07D221/28—Morphinans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
- C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/08—Bridged systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Child & Adolescent Psychology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE3518525 | 1985-05-23 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES555200A0 true ES555200A0 (es) | 1988-05-01 |
| ES8802318A1 ES8802318A1 (es) | 1988-05-01 |
Family
ID=6271435
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES555200A Expired ES8802318A1 (es) | 1985-05-23 | 1986-05-21 | Procedimiento para la produccion de derivados del morfinano |
Country Status (18)
| Country | Link |
|---|---|
| JP (1) | JPS61271275A (es) |
| AU (1) | AU594954B2 (es) |
| BE (1) | BE904796A (es) |
| DK (1) | DK240386A (es) |
| ES (1) | ES8802318A1 (es) |
| FI (1) | FI862124A7 (es) |
| FR (1) | FR2582309B1 (es) |
| GB (1) | GB2175898B (es) |
| GR (1) | GR861318B (es) |
| HU (1) | HU196376B (es) |
| IL (1) | IL78872A0 (es) |
| IT (1) | IT1203791B (es) |
| LU (1) | LU86435A1 (es) |
| NL (1) | NL8601188A (es) |
| NZ (1) | NZ216250A (es) |
| PH (1) | PH23341A (es) |
| SE (1) | SE8602308L (es) |
| ZA (1) | ZA863873B (es) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4857533A (en) * | 1988-12-15 | 1989-08-15 | Baker Cummins Pharmaceuticals, Inc. | Method of treatment for autoimmune diseases |
| US4863928A (en) * | 1989-01-04 | 1989-09-05 | Baker Cummins Pharmaceuticals, Inc. | Method of treatment for arthritic and inflammatory diseases |
| US4923875A (en) * | 1989-07-10 | 1990-05-08 | Baker Cummins Pharmaceuticals, Inc. | Method for treatment of mast cell-mediated dermatologic disorders |
| JP2906654B2 (ja) * | 1989-11-28 | 1999-06-21 | 東レ株式会社 | 免疫抑制剤及びその製造方法 |
| US5057322A (en) * | 1990-08-10 | 1991-10-15 | Baker Cummins Dermatologicals, Inc. | Method of treating mast cell disease |
| WO1993015081A1 (en) | 1992-01-23 | 1993-08-05 | Toray Industries, Inc. | Morphinan derivative and medicinal use |
| CA2144770C (en) * | 1993-07-19 | 2006-02-28 | Hiroshi Nagase | Brain cell protective agent |
| WO1995003308A1 (fr) * | 1993-07-23 | 1995-02-02 | Toray Industries, Inc. | Derive de morphinane et application medicale |
| AU706370B2 (en) | 1996-01-10 | 1999-06-17 | Smithkline Beecham Spa | Heterocycle-condensed morphinoid derivatives (II) |
| ES2285733T3 (es) * | 1996-11-25 | 2007-11-16 | Toray Industries, Inc. | Agente antipruritico. |
| WO1999005146A1 (en) * | 1997-07-25 | 1999-02-04 | Toray Industries, Inc. | Hyponatremia remedies |
| MXPA04011327A (es) | 2002-05-17 | 2005-08-15 | Jenken Biosciences Inc | Opioides y compuestos similares a opioides y usos de los mismos. |
| US7501433B2 (en) | 2002-05-17 | 2009-03-10 | Jenken Biosciences, Inc. | Opioid and opioid-like compounds and uses thereof |
| US7923454B2 (en) | 2002-05-17 | 2011-04-12 | Jenken Biosciences, Inc. | Opioid and opioid-like compounds and uses thereof |
| JP4957489B2 (ja) * | 2002-10-09 | 2012-06-20 | 東レ株式会社 | 含窒素環状置換基を有するモルヒナン誘導体またはその薬理学的に許容される酸付加塩を含有する医薬 |
| US8017622B2 (en) | 2003-05-16 | 2011-09-13 | Jenken Biosciences, Inc. | Opioid and opioid-like compounds and uses thereof |
| JP2011512360A (ja) * | 2008-02-14 | 2011-04-21 | アルカーメス，インコーポレイテッド | 選択的オピオイド化合物 |
| US8987287B2 (en) * | 2012-12-14 | 2015-03-24 | Purdue Pharma L.P. | Spirocyclic morphinans and their use |
| US8980906B2 (en) * | 2012-12-14 | 2015-03-17 | Purdue Pharma L.P. | Pyridonemorphinan analogs and biological activity on opioid receptors |
| AR096851A1 (es) * | 2013-07-11 | 2016-02-03 | H Lundbeck As | Sales que no forman hidratos ni solvatos de nalmefeno |
| JP6360915B2 (ja) * | 2014-06-13 | 2018-07-18 | パーデュー、ファーマ、リミテッド、パートナーシップ | アザモルフィナン誘導体及びその使用 |
-
1986
- 1986-05-09 HU HU861934A patent/HU196376B/hu not_active IP Right Cessation
- 1986-05-12 NL NL8601188A patent/NL8601188A/nl not_active Application Discontinuation
- 1986-05-19 GB GB8612159A patent/GB2175898B/en not_active Expired
- 1986-05-19 PH PH33785A patent/PH23341A/en unknown
- 1986-05-21 AU AU57637/86A patent/AU594954B2/en not_active Expired - Fee Related
- 1986-05-21 NZ NZ216250A patent/NZ216250A/en unknown
- 1986-05-21 BE BE1/011493A patent/BE904796A/fr not_active IP Right Cessation
- 1986-05-21 SE SE8602308A patent/SE8602308L/xx not_active Application Discontinuation
- 1986-05-21 GR GR861318A patent/GR861318B/el unknown
- 1986-05-21 IL IL78872A patent/IL78872A0/xx unknown
- 1986-05-21 ES ES555200A patent/ES8802318A1/es not_active Expired
- 1986-05-21 FI FI862124A patent/FI862124A7/fi not_active Application Discontinuation
- 1986-05-22 LU LU86435A patent/LU86435A1/fr unknown
- 1986-05-22 DK DK240386A patent/DK240386A/da not_active Application Discontinuation
- 1986-05-22 JP JP61118984A patent/JPS61271275A/ja active Pending
- 1986-05-23 ZA ZA863873A patent/ZA863873B/xx unknown
- 1986-05-23 IT IT48050/86A patent/IT1203791B/it active
- 1986-05-23 FR FR8607367A patent/FR2582309B1/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| FI862124L (fi) | 1986-11-24 |
| SE8602308L (sv) | 1986-11-24 |
| BE904796A (fr) | 1986-11-21 |
| GB2175898B (en) | 1989-07-05 |
| AU594954B2 (en) | 1990-03-22 |
| IL78872A0 (en) | 1986-09-30 |
| HU196376B (en) | 1988-11-28 |
| NZ216250A (en) | 1990-04-26 |
| IT1203791B (it) | 1989-02-23 |
| NL8601188A (nl) | 1986-12-16 |
| GB2175898A (en) | 1986-12-10 |
| FR2582309A1 (fr) | 1986-11-28 |
| SE8602308D0 (sv) | 1986-05-21 |
| ES8802318A1 (es) | 1988-05-01 |
| JPS61271275A (ja) | 1986-12-01 |
| ZA863873B (en) | 1988-01-27 |
| FI862124A0 (fi) | 1986-05-21 |
| PH23341A (en) | 1989-07-14 |
| GR861318B (en) | 1986-09-19 |
| LU86435A1 (fr) | 1986-12-05 |
| GB8612159D0 (en) | 1986-06-25 |
| IT8648050A0 (it) | 1986-05-23 |
| HUT41737A (en) | 1987-05-28 |
| FI862124A7 (fi) | 1986-11-24 |
| DK240386A (da) | 1986-11-24 |
| FR2582309B1 (fr) | 1989-08-18 |
| AU5763786A (en) | 1986-11-27 |
| DK240386D0 (da) | 1986-05-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES557723A0 (es) | Procedimiento para la produccion de tiazoles | |
| ES556927A0 (es) | Procedimiento para la produccion de derivados de la 13-betamilbemicina | |
| ES556320A0 (es) | Procedimiento para la obtencion de derivados del 3-fenil-4-cianopirrol | |
| ES555200A0 (es) | Procedimiento para la produccion de derivados del morfinano | |
| AR231130A1 (es) | Procedimiento para la produccion de nuevos derivados de n-benzoazepinalquil-n-fenilalquil-amina | |
| ES557643A0 (es) | Procedimiento para la obtencion de derivados de acidos benzoheterociclilalcanoicos | |
| IT1190018B (it) | Procedimento per la produzione di beta-allumina | |
| ES556313A0 (es) | Procedimiento para la produccion de gamma-butirolactona. | |
| ES529774A0 (es) | Procedimiento para la produccion de derivados de 1-sulfo-2-oxoacetidina | |
| ES552935A0 (es) | Procedimiento para la produccion de d-l-amino acidos | |
| ES556598A0 (es) | Procedimiento para la preparacion de derivados de 13beta-alquil-milbemicina | |
| ES556514A0 (es) | Procedimiento para la preparacion de derivados de 2-oxi-4h-3, 1-benzoxazin-4-ona | |
| ES553377A0 (es) | Procedimiento para la produccion de 2,4,6-tris-(amino-fenilamino)-triacinas | |
| ES555709A0 (es) | Procedimiento para preparar nuevos derivados del fenantreno | |
| ES555278A0 (es) | Procedimiento para la obtencion de derivados de diclorociclopropilalquilhidroxialquil-azol | |
| ES528699A0 (es) | Procedimiento para la produccion de derivados de halogenazolilpropano | |
| PT81950A (fr) | Procede de preparation de derives de 3-hydroxy-3-phenylpiperidine | |
| AR227574A1 (es) | Procedimiento para la produccion de nuevos derivados de apovincaminol | |
| MX160682A (es) | Procedimiento para la produccion de derivados de n-fosfonometilglicina | |
| ES554339A0 (es) | Procedimiento para la obtencion de derivados de 1,4-dihidropiridina | |
| ES549738A0 (es) | Procedimiento para la produccion de derivados de 1,4-dihi- dropiridina | |
| ES545451A0 (es) | Procedimiento para la fabricacion de derivados de pirrolidi-na | |
| ES539586A0 (es) | Procedimiento para la produccion de derivados de bencimida- zol | |
| ES539587A0 (es) | Procedimiento para la produccion de derivados de bencimida- zol | |
| ES555343A0 (es) | Procedimiento para la preparacion de nuevos derivados de morfina |